Search clinical trials for: Prasugrel 5mg

Total 12628 results

Germano Di Sciascio
Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Department of Advanced... and other collaborators

Completed

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study (PROMICRO-3)

Coronary Artery Disease

Belgium
David Antoniucci
A.R. CARD Onlus Foundation

Terminated

BLeeding Events and Maintenance DoSe of PraSugrel (BLESS)

Acute Coronary Syndrome | Adverse Reaction to Antiplatelet Agent

Italy
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

A Study of Prasugrel in Healthy Participants

Healthy Volunteers

United States
Azienda Ospedaliera Universitaria Integrata Verona
University of Milan

Unknown

Prasugrel in Severe COVID-19 Pneumonia (PARTISAN)

Thrombosis | COVID19

Italy
Maasstad Hospital
Daiichi Sankyo, Inc.; MicroPort Orthopedics Inc.; Research Maatschap Cardiologen...

Completed

CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI (CompareCrush)

Cardiovascular Diseases

Netherlands
GlaxoSmithKline

Completed

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

Asthma

Germany, South Africa, Bulgaria
Seoul National University Hospital
Boston Scientific Korea Co. Ltd; Dio; Terumo Corporation; Abbott

Unknown

Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

Acute Coronary Syndrome

Korea, Republic of
University of Patras

Completed

High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)

Platelet Reactivity

Greece
J2H Biotech

Completed

Phase 1 Study to Investigate Safety, Tolerability, PK/PK of J2H-1702 in Healthy Males

Non-alcoholic Steatohepatitis

Korea, Republic of
Attikon Hospital

Completed

Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction (ALTIC-2)

Myocardial Infarction | Coronary Artery Disease | Diabetes Mellitus | Renal Disease

Greece
Gyeongsang National University Hospital

Completed

Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome

Bleeding | Acute Coronary Syndrome | Platelet Thrombus

Korea, Republic of
University of Florida

Completed

Prasugrel Re-load Strategies

Coronary Artery Disease

United States
University of Milan

Completed

The Effect of Prasugrel on Bronchial Hyperreactivity and on Markers of Inflammation in Patients With Chronic Asthma (PRINA)

Chronic Asthma

Italy
Asan Medical Center

Unknown

Clinical Trial to Characterize Pharmacokinetic-pharmacodynamic (PKPD) of Prasugrel 10 mg or 30 mg in Healthy Volunteers (PRAS-AM)

Healthy

Korea, Republic of
Medstar Health Research Institute

Completed

The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel (SWITCH 600/60)

Acute Coronary Syndrome

United States
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event (SWAP)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States
University of Florida

Completed

Pharmacological Effects of Crushing Prasugrel in STEMI Patients

Coronary Artery Disease

United States
VA Office of Research and Development

Completed

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

Coronary Artery Bypass

United States
Dong-A University

Completed

Prasugrel With Lower Dose - Loading Dose (PRELOAD-LD)

Coronary Artery Disease

Korea, Republic of
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company

Completed

Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)

Acute Coronary Syndrome (ACS)

Taiwan
Eli Lilly and Company

Completed

A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet

Sickle Cell Disease

United States
University of Edinburgh
NHS Lothian

Completed

Cardiovascular Effects of Apelin In Healthy Volunteers

Healthy

United Kingdom
Research Maatschap Cardiologen Rotterdam Zuid
Abbott Medical Devices

Recruiting

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

ST Elevated Myocardial Infarction | Dual Antiplatelet Therapy

Netherlands, Germany, Italy
Ottawa Heart Institute Research Corporation
Spartan Bioscience Inc.

Completed

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (RAPID GENE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Stable Coronary Artery Disease

Canada
Eli Lilly and Company

Completed

Study of Prasugrel in Korean Healthy Male Volunteers

Healthy Volunteers

Korea, Republic of
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults

Anemia, Sickle Cell

United Kingdom
Eli Lilly and Company
Daiichi Sankyo, Inc.

Terminated

A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)

Sickle Cell Disease

United Arab Emirates, Italy, United States, Egypt, United Kingdom, Belgium, Turkey, Brazil, Canada, Ghana, Kenya, Lebanon, Oman, Saudi Arabia
Rigshospitalet, Denmark

Completed

Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient

ST-elevation Myocardial Infarction | Ischemic Heart Disease | Heart Disease

Denmark
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

Prasugrel Versus Placebo in Adult Sickle Cell Disease

Sickle Cell Anemia

United States
Genor Biopharma Co., Ltd.

Unknown

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

Rheumatoid Arthritis

China
Gyeongsang National University Hospital
U&I Corporation

Unknown

Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION) (E-5TION)

Coronary Artery Disease

Korea, Republic of
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction (ACCOAST)

Acute Coronary Syndromes

Israel, Italy, Germany, Belgium, Poland, France, Austria, Netherlands, Turkey, Hungary, Lithuania, Romania, Canada, Slovakia, Czech Republic, Finland, Latvia, Portugal, Sweden
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (Crescent)

Sickle Cell Disease

United States
Asan Medical Center

Completed

PKPD Study of Ticagrelor and Prasugrel in Healthy Korean Males

Healthy

Korea, Republic of
Ottawa Heart Institute Research Corporation
Spartan Bioscience Inc.

Completed

Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI) (RAPID STEMI)

STEMI

Canada
Hanmi Pharmaceutical Company Limited

Completed

Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet (PGP inhibitor)

Healthy

Korea, Republic of
Collegium Medicum w Bydgoszczy

Not yet recruiting

Prasugrel Or Ticagrelor De-escalation in NSTE-ACS (PROTEUS)

Unstable Angina | Non ST Segment Elevation Acute Coronary Syndrome | Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)

Poland
Dong-A University

Terminated

Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction

ST-Segment Elevation Myocardial Infarction

Korea, Republic of
Institut de Recherches Internationales Servier

Completed

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

Alzheimer's Disease

Brazil, South Africa, Chile, Hungary, Bulgaria, Czechia, Germany, Japan, Mexico, Poland, Russian Federation, Slovakia
Ascletis Pharmaceuticals Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

China
Brigham and Women's Hospital

Completed

Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data

Antiplatelet

United States
University Hospital, Geneva

Completed

Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel

Acquired Platelet Disorder

Switzerland
Vastra Gotaland Region
Region Skane; Region Örebro County; Region Västerbotten; Jämtland County Council... and other collaborators

Recruiting

Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome (SWITCH)

Acute Coronary Syndrome

Sweden
Pfizer

Completed

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia

Schizophrenia

United States
Taichung Veterans General Hospital

Completed

Effects of Cranberry Extractive on the Lipid Profiles in Subjects With Type 2 Diabetes

Type 2 Diabetes

Taiwan
Helixmith Co., Ltd.

Completed

Safety Study of Gene Therapy in Treating Lower Leg Ischemia

Critical Limb Ischemia

United States
University of Pecs

Completed

Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity (TREAT-HPR)

Acute Coronary Syndrome

Hungary
Eli Lilly and Company

Completed

A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Heart Diseases | Cardiovascular Diseases

United States, Canada
Dong-A University

Completed

Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)

Acute Coronary Syndrome

Korea, Republic of
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Completed

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

Healthy Volunteer

China

Search clinical trials for: Prasugrel 5mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations